Haymarket Media, Inc. has acquired the American Journal of Endocannabinoid Medicine. Haymarket is making an additional investment in AJEM to increase its engagement with healthcare professionals and fulfill its mission to educate and inform the medical community on cannabinoid-based therapy.

Physicians are not trained in the endocannabinoid system in medical school. Yet, they are increasingly tasked with caring for patients using cannabinoid-based medicine—often in conjunction with other pharmaceuticals. AJEM fills this knowledge gap and provides the medical community widespread access to quality, trusted, peer-reviewed content.

“It was important for us …

Full story available on Benzinga.com